Factores de riesgo asociados a Pérdida de Sensibilidad Protectora en pacientes con Diabetes en la Unidad Multidisciplinaria de Pie Diabético

• Canata, María Gabriela ^[1] ; Rodríguez, María Gloria ^[1] ; López, Helen ^[1] ; Romero, Fabiola ^[1] ; Báez, Santiago ^[1] ; Ortiz, Ignacio ^[1]
  1. [1] Universidad Nacional de Asunción

     Universidad Nacional de Asunción

     Paraguay

     
• Localización: Anales de la Facultad de Ciencias Médicas, ISSN-e 2313-2841, Vol. 54, Nº. 1, 2021, págs. 61-66
• Idioma: español
• Títulos paralelos:
  • Risk factors associated with Loss of Protective Sensitivity in Diabetes patients in the Multidisciplinary Unit of Diabetic Foot
• Enlaces
  • Texto completo
• Resumen
  • español

    Introducción: Identificar factores de riesgo para pérdida de la sensibilidad protectora es fundamental para prevenir el Pie Diabético. Objetivos: Analizar los factores de riesgo asociados a la pérdida de la sensibilidad protectora en pacientes con diabetes mellitus y sus complicaciones. Materiales y métodos: diseño observacional, de casos y controles. Se incluyó pacientes de ambos sexos, con diabetes mellitus; ≥ 18 años, a quienes se realizó el Test de monofilamento en la Unidad Multidisciplinaria Hospital de Clínicas, de enero 2014 a julio 2019. Factores de riesgo considerados: edad, años de diabetes mellitus, Hba1c, HTA, dislipidemia; se tuvo en cuenta las complicaciones: retinopatía, enfermedad arterial periférica = ITB <0,9 derecho e izquierdo, enfermedad renal= ClCr <60 ml/min/m2 (MDRD), amputaciones (mayores y menores). Resultados: De 100 pacientes; 33% con pérdida de la sensibilidad protectora; edad 59±9,7 años; 55% masculino. Factores de riesgo: edad: 57,7±1,0 años sin pérdida de la sensibilidad protectora y 61,2±9 años con pérdida de la sensibilidad protectora, p=0.08; años de diabetes mellitus 9,4±8,4 vs 11,5± 8,7 p=0,20; HbA1C 8,8± 2,7% vs 9,1±2% p=0,50; HTA 63,5% vs 75,6% p=0,20; dislipidemias 75,9% vs 57,69%, p=0,09; complicaciones con pérdida de la sensibilidad protectora: retinopatía 88% vs 57,5% OR=1,67, p=0,02. ClCr 84±40,3 ml/min vs 90,9±30,4, p=0,40. Enfermedad arterial periférica derecha 27,78% vs 11,1% OR=0,1, p=0,10; enfermedad arterial periférica izquierda 20% vs 7 15,5% OR=1 p=0,60; amputación 17,5% vs 7,9% OR=2,01, p=0,06. Conclusión: con pérdida de la sensibilidad protectora: la edad, años de diabetes mellitus fueron mayores. HTA fue más frecuente y Hba1c más elevada; nefropatía, enfermedad arterial periférica y amputación con mayor frecuencia, todas no significativas. La retinopatía fue más frecuente en forma significativa.

  • English

    Introduction: Identifying risk factors for loss of protective sensitivity is essential to prevent Diabetic Foot. Objectives: To analyze the risk factors associated with the loss of protective sensitivity in patients with diabetes mellitus and its complications. Materials and methods: observational, case-control design. Patients of both sexes were included, with diabetes mellitus; ≥ 18 years, who underwent the Monofilament Test in the Multidisciplinary Unit Hospital de Clínicas, from January 2014 to July 2019. Risk factors considered: age, years of diabetes mellitus, Hba1c, HT, dyslipidemia; Complications were taken into account: retinopathy, peripheral arterial disease = ABI <0.9 right and left, kidney disease = CrCl <60 ml / min / m2 (MDRD), amputations (major and minor). Results: Of 100 patients; 33% with loss of protective sensitivity; age 59 ± 9.7 years; 55% male. Risk factors: age: 57.7 ± 1.0 years without loss of protective sensitivity and 61.2 ± 9 years with loss of protective sensitivity, p = 0.08; years of diabetes mellitus 9.4 ± 8.4 vs 11.5 ± 8.7 p = 0.20; HbA1C 8.8 ± 2.7% vs 9.1 ± 2% p = 0.50; HTN 63.5% vs 75.6% p = 0.20; dyslipidemias 75.9% vs 57.69%, p = 0.09; complications with loss of protective sensitivity: retinopathy 88% vs 57.5% OR = 1.67, p = 0.02. CrCl 84 ± 40.3 ml / min vs 90.9 ± 30.4, p = 0.40. Right peripheral arterial disease 27.78% vs 11.1% OR = 0.1, p = 0.10; left peripheral arterial disease 20% vs 7 15.5% OR = 1 p = 0.60; 17.5% amputation vs 7.9% OR = 2.01, p = 0.06. Conclusion: with loss of protective sensitivity: age, years of diabetes mellitus were older. HBP was more frequent and Hba1c higher; nephropathy, peripheral arterial disease and amputation with greater frequency, all not significant. Retinopathy was significantly more frequent.

• Referencias bibliográficas
  • Ahlam A. Amour et al. Prevalence, Patterns, and Factors Associated with Peripheral Neuropathies among Diabetic Patients at Tertiary Hospital...
  • Bonilla G et al. Demographic and clinical characteristics of dominican adults admitted to a diabetic foot clinic in the Dominican Republic,...
  • International Diabetes Federation. Clinical Practice Recommendation on the Diabetic Foot: A guide for health care professionals: International...
  • Piaggesi A, Apelqvist J (eds): The Diabetic Foot Syndrome. Front Diabetes. Basel, Karger, 2018, vol 26, pp 1-18.
  • Ramirez-Perdomo C, Perdomo-Romero A, Rodríguez-Vélez M. Knowledge and practices for diabetic foot prevention. Rev Gaúcha Enferm. 2019;40:e20180161.
  • González de la Torre H. et al. Clasificaciones de lesiones en pie diabético II. El problema permanece. Gerokomos [Internet]. 2018 [citado...
  • l Consensus on the diabetic foot Working Group on the Diabetic Foot (IWGDF).
  • Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings....
  • Yokoyama H, Tsuji T, Hayashi S, Kabata D, Shintani A. Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in...
  • Richard JL, Lavigne JP, Got I, et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study....
  • Browlee M, Aiello L, Cooper M et al. Pie Diabetico. Complicaciones de la diabetes mellitus. Cap 33. Williams textbook of Endocrinology. 13th...
  • Boulton AJ. Diabetic neuropathy: is pain God’s greatest gift to mankind?. Semin Vasc Surg. 2012;25(2):61-65. doi:10.1053/j.semvascsurg.2012.04.009
  • Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020. Diabetes Care 2020 Jan; 43 (Supplement 1): S135-S151.
  • Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Current Diabetes Reports. 2019 Aug;19(10):86....
  • Yokoyama H, Yokota Y, Tada J, Kanno S. Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes....
  • Bartus, C. L., & Margolis, D. J. (2004). Reducing the incidence of foot ulceration and amputation in diabetes. Current Diabetes Reports,...
  • Hinchliffe R et al. IWGDF Guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a foot ulcer and...
  • Gorostidi M et al. Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la Enfermedad...
  • Van Netten et al. Definitions and criteria for diabetic foot disease. Diab Metab Res Rev. 2020. e3268.”
  • Ramírez- López P, Acevedo Giles O, González Pedraza Avilés A. Neuropatía diabética: frecuencia, factores de riesgo y calidad de vida en pacientes...
  • Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and Its Associated Determinants of Diabetic Peripheral Neuropathy...
  • Skopljak, Amira & Sukalo, Aziz & Batic-Mujanovic, Olivera & Becirevic, Mustafa & Tiric Campara, Merita & Zunic, Lejla....
  • Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type...
  • Zakaria Chahbi et al. The prevalence of painful diabetic neuropathy in 300 Moroccan diabetics. Pan African Medical Journal. 2018;31:158. doi:10.11604/pamj.2018.31.158.14687.
  • Enciso A. Factores de riesgo asociados al pie diabético. Rev. virtual Soc. Parag. Med. Int. 2016; 3(2):58-70.